Rennova Health, Inc.
RNVAOTCHealthcare● Active
$0.00
+$0.00(+0.00%)
Market Cap$4305132
P/E Ratio—
52W High$0.0001
52W Low$0.0001
Rennova Health, Inc. (RNVA) · Cash Flow
Annual, quarterly, or TTM views · SEC 10-K & 10-Q via FMP · adjust period and M/B/T below.
FMP · RNVA · as of 2026-06-15
Financial statements
Operating CF · CapEx · Free Cash Flow
| Breakdown | 2023-12 | 2022-12 | 2021-12 | 2020-12 | 2019-12 |
|---|---|---|---|---|---|
| Operating Activities | |||||
| Net Income | ($0.55M) | ($3.35M) | ($5.27M) | ($17.64M) | ($46.58M) |
| Depreciation & Amort. | $0.31M | $0.47M | $0.64M | $0.70M | $0.80M |
| Stock-Based Comp. | $0.00M | $0.00M | $0.00M | $0.00M | $0.00M |
| Change in Working Capital | $2.68M | $3.62M | $4.44M | $9.93M | $8.89M |
| Net Cash from Operations | $3.39M | ($0.22M) | ($8.91M) | ($16.93M) | ($13.53M) |
| Investing Activities | |||||
| Capital Expenditure | ($0.35M) | ($0.04M) | $0.00M | ($0.37M) | ($0.00M) |
| Purchases of Investments | $0.00M | $0.00M | $0.00M | $0.00M | $0.00M |
| Sales of Investments | $0.00M | $0.00M | $0.00M | $0.00M | $0.00M |
| Net Cash from Investing | ($1.53M) | ($0.91M) | ($0.37M) | ($0.29M) | ($0.66M) |
| Financing Activities | |||||
| Common Stock Repurchased | $0.00M | ($0.00M) | ($0.00M) | ($0.00M) | ($0.00M) |
| Dividends Paid | $0.00M | $0.00M | $0.00M | $0.00M | $0.00M |
| Debt Issued / Repaid | ($2.31M) | ($0.20M) | $0.52M | $4.19M | $14.55M |
| Net Cash from Financing | ($2.31M) | $0.90M | $9.99M | $17.23M | $14.20M |
| Free Cash Flow | |||||
| Free Cash Flow | $3.04M | ($0.25M) | ($8.91M) | ($17.30M) | ($13.53M) |
| FCF Margin %(computed) | 16.25% | -1.95% | -276.46% | -240.26% | -84.54% |
Data source: Financial Modeling Prep · Last updated: 2026-06-15 · USD · M
Explore more Rennova Health, Inc. data
About Rennova Health, Inc. (RNVA) Cash Flow Statement
Rennova Health, Inc. generated operating cash flow of $0.00B and free cash flow of $0.00B for 2023 — a FCF margin of 16.25%. Capital expenditure was ($0.00B).
Frequently asked questions
RNVA · 4 questionsRennova Health, Inc. generated free cash flow of $0.00B for 2023, up 1297.6% year-over-year.
RNVA free cash flowFCF margincash flow yield
· Source: FMP /stable/cash-flow-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-15